As of the latest Form 4 filed Jun 18, 2026.
What Assembly Biosciences Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 16 most recent filings for ASMB.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2026-06-17 | Bjorkquist Jeanette M PFO and PAO | SSale | −29.00 | $23.25 | $674.25 | No | Form 4 ↗ |
| 2026-06-05 | 2026-03-29 | Gaggar Anuj Chief Medical Officer | AAward | +14.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-03-29 | White Nicole S Chief Manufacturing Officer | AAward | +14.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-03-29 | Bjorkquist Jeanette M PFO and PAO | AAward | +3.50K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-03-29 | Delaney William E IV Chief Scientific Officer | AAward | +14.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-03-29 | Okazaki Jason A CEO and President | AAward | +50.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-26 | GILEAD SCIENCES, INC. 10% owner | AAward | +472K | $26.50 | $12.5M | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | Bjorkquist Jeanette M PFO and PAO | SSale | −16.00 | $27.49 | $439.84 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | Bjorkquist Jeanette M, PFO and PAO | SSale | −312.00 | $26.65 | $8.31K | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | White Nicole S Chief Manufacturing Officer | SSale | −9.00 | $27.49 | $247.41 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-30 | White Nicole S, Chief Manufacturing Officer | SSale | −188.00 | $26.65 | $5.01K | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-29 | Bjorkquist Jeanette M PFO and PAO | AAward | +6.50K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-29 | White Nicole S Chief Manufacturing Officer | AAward | +26.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-29 | Gaggar Anuj Chief Medical Officer | AAward | +26.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-29 | Delaney William E IV Chief Scientific Officer | AAward | +26.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-29 | Okazaki Jason A CEO and President | AAward | +94.3K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ASMB’s full analysis or the market-wide insider trading feed. The tabs above jump to ASMB’s other SEC data.
Source: SEC Form 4 filings for ASMB, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.